Chemical reduction of Cp*Ta[N( i Pr)C(Me)N( i Pr)](Cl) 3 (Cp* = η 5 -C 5 Me 5 ) ( 1 ) with 2.5 equiv of potassium graphite (KC 8 ) in tetrahydrofuran (THF) provides a 70% yield of {Cp*Ta[N( i Pr)C(Me)N( i Pr)]Cl} 2 (μη:η-ηN 2 ) ( 2 ). With 4 equiv of KC 8, reduction of 1 provides a 34% isolated yield of {Cp*Ta[N( i Pr)C(Me)N( i Pr)]} 2 (μη:η-N 2 ) ( 3 ). Single-crystal X-ray analyses of 2 and 3 provide N−N bond lengths of 1.288(10) and 1.313(4) Å, respectively, which is indicative of substantial hydrazido [μ-N 2 ] 4- character for these compounds. While 2 is thermally robust and chemically inert to hydrogenation and hydrosilylation in solution, above 0 °C, 3 spontaneously and quantitatively converts to {Cp*Ta[N( i Pr)C(Me)N( i Pr)N]} 2 ( 4 ) in a 7:1 ratio of cis and trans isomers. Crystallographic analyses of both cis - and trans - 4 reveal an absence of N−N bonding within the four-membered ring. Hydrosilylation of 3 at 25 °C using PhSiH 3 occurs with 1,4-addition across the Ta N−N Ta framework to provide a quantitative yield of the hydrosilylated product, 5 . Finally, hydrogenation of 3 in pentane at 0 °C, provides an 80% yield of the stereospecific 1,4-addition dihydride product 6 . Single-crystal X-ray analyses of 5 and 6 provide N−N bond lengths of 1.284(4) and 1.307(6) Å, respectively. Finally, cis - 4 was found to readily react with PhSiH 3 at 25 °C to provide 7 as the product of stereospecific ring-opening via σ-bond metathesis of a Ta−N single bond. Crystallographic analysis of 7 confirms the absence of bridging hydrides and the noncyclic nature of this compound.
No takes yet. Share an insight, caveat, or question.
Hirotsu et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: